Board Meetings for BLISSGVS
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| BLISSGVS | Bliss GVS Pharma Limited | 09 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| BLISSGVS | Bliss GVS Pharma Limited | 17 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend | |
| BLISSGVS | Bliss GVS Pharma Limited | 19 Jan 2018 | Results | To consider inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2017. | |
| BLISSGVS | Bliss GVS Pharma Limited | 11 Jan 2018 | Others | for considering disinvestment of subsidiary business. | |
| BLISSGVS | Bliss GVS Pharma Limited | 30 Nov 2017 | Results | to consider inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter & half year ended September 30, 2017. | |
| BLISSGVS | Bliss GVS Pharma Limited | 06 Sept 2017 | Results | To consider inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the year ended June 30, 2017. | |
| BLISSGVS | Bliss GVS Pharma Limited | 16 May 2017 | Results/Dividend | to consider inter alia, the Audited Standalone and Consolidated Financial Results of the Company for the year ended March 31, 2017 and dividend if any. | |
| BLISSGVS | Bliss GVS Pharma Limited | 09 Feb 2017 | Results | To consider inter alia, the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2016. | |
| BLISSGVS | Bliss GVS Pharma Limited | 26 Oct 2016 | Results | To consider inter alia, the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2016. Further, Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with the provision of the code of fair disclosure of the Company, the trading window of the Company will be closed from October 18, 2016 to October 29, 2016 (both days inclusive). | |
| BLISSGVS | Bliss GVS Pharma Limited | 27 Jul 2016 | Results | To consider inter alia, the Un-Audited Financial Results of the Company for the quarter ended June 30, 2016. | |
| BLISSGVS | Bliss GVS Pharma Limited | 24 May 2016 | Results/Dividend | To consider inter alia, the Audited Financial Results of the Company for the quarter and year ended March 31, 2016 and dividend if any. | |
| BLISSGVS | Bliss GVS Pharma Limited | 11 Feb 2016 | Results | To consider inter alia, the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2015. | |
| BLISSGVS | Bliss GVS Pharma Limited | 09 Nov 2015 | Results | To consider inter alia, the Un-Audited Financial Results of the Company tor the quarter ended September 30, 2015. | |
| BLISSGVS | Bliss GVS Pharma Limited | 14 Aug 2015 | Results | to consider inter alia the un-audited financial results of the company for the Quarter ended June 30, 2015. | |
| BLISSGVS | Bliss GVS Pharma Limited | 29 May 2015 | Results/Dividend | To consider interalia, 1. The Audited Financial Results of the Company for the year ended March 31, 2015. 2. Dividend, if any. |